Posted On: 12/06/2014 6:28:40 PM
Post# of 63824
$BIOL recovery candle . $2.97
called 1/4/14 $2.60
Website
10-Q 11/7/14
Summary
Shares Outstanding: 43.95M
Float: 31.92M
% Held by Insiders: 31.11%
% Held by Institutions: 25.30%
Shares Short (as of Nov 14, 2014): 4.04M
Short Ratio (as of Nov 14, 2014): 34.90
Short % of Float (as of Nov 14, 2014): 12.20%
Shares Short (prior month): 4.16M
60% Sell
Recent trades
Headlines
Monday, December 1, 2014
BIOLASE Launches New EPIC™ X diode laser in the United States; Now Dentists Can Delight Their Patients, FasterPR Newswire
Friday, November 28, 2014
BIOLASE Introduces a New Commitment to Customer Care, Quality and Innovation at Greater New York Dental Meeting 2014Business Wire
Wednesday, November 19, 2014
Biolase Announces Management ChangeBusiness Wire
Saturday, November 15, 2014
BIOLASE, INC FinancialsEDGAR Online Financials
Sunday, November 9, 2014
10-Q for BIOLASE, Inc.Company Spotlight
Friday, November 7, 2014
BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,EDGAR Online
Tuesday, November 4, 2014
BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online
BIOLASE Reports 2014 Third Quarter ResultsBusiness Wire
BIOLASE to Raise $35 Million from Institutional and Individual Investors in Private PlacementBusiness Wire
Thursday, October 23, 2014
BIOLASE® to Host Third Quarter Financial Results Conference Call on November 4, 2014Business Wire
Monday, September 15, 2014
George Soros Picks KIOR, RSH, BIOL Soar On Mondayat TheStreet
Sunday, September 14, 2014
Biolase management overhauled amid bid to stanch a decade of red inkat Los Angeles Times
Tuesday, September 2, 2014
BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial StateEDGAR Online
BIOLASE Names Jeffrey M. Nugent Permanent President and Chief Executive OfficerBusiness Wire
BIOLASE Names Alexander K. Arrow, M.D. Chief Medical OfficerBusiness Wire
Friday, August 29, 2014
BIOLASE Holds Annual Meeting of StockholdersBusiness Wire
Monday, August 25, 2014
BIOLASE Creates Global Commercialization TeamBusiness Wire
Thursday, August 14, 2014
BIOLASE Announces Formation of Dental Professional Advisory BoardBusiness Wire
BIOLASE, INC Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Friday, August 8, 2014
BIOLASE, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online
called 1/4/14 $2.60
Website
10-Q 11/7/14
Summary
Shares Outstanding: 43.95M
Float: 31.92M
% Held by Insiders: 31.11%
% Held by Institutions: 25.30%
Shares Short (as of Nov 14, 2014): 4.04M
Short Ratio (as of Nov 14, 2014): 34.90
Short % of Float (as of Nov 14, 2014): 12.20%
Shares Short (prior month): 4.16M
60% Sell
Recent trades
Headlines
Monday, December 1, 2014
BIOLASE Launches New EPIC™ X diode laser in the United States; Now Dentists Can Delight Their Patients, FasterPR Newswire
Friday, November 28, 2014
BIOLASE Introduces a New Commitment to Customer Care, Quality and Innovation at Greater New York Dental Meeting 2014Business Wire
Wednesday, November 19, 2014
Biolase Announces Management ChangeBusiness Wire
Saturday, November 15, 2014
BIOLASE, INC FinancialsEDGAR Online Financials
Sunday, November 9, 2014
10-Q for BIOLASE, Inc.Company Spotlight
Friday, November 7, 2014
BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,EDGAR Online
Tuesday, November 4, 2014
BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online
BIOLASE Reports 2014 Third Quarter ResultsBusiness Wire
BIOLASE to Raise $35 Million from Institutional and Individual Investors in Private PlacementBusiness Wire
Thursday, October 23, 2014
BIOLASE® to Host Third Quarter Financial Results Conference Call on November 4, 2014Business Wire
Monday, September 15, 2014
George Soros Picks KIOR, RSH, BIOL Soar On Mondayat TheStreet
Sunday, September 14, 2014
Biolase management overhauled amid bid to stanch a decade of red inkat Los Angeles Times
Tuesday, September 2, 2014
BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial StateEDGAR Online
BIOLASE Names Jeffrey M. Nugent Permanent President and Chief Executive OfficerBusiness Wire
BIOLASE Names Alexander K. Arrow, M.D. Chief Medical OfficerBusiness Wire
Friday, August 29, 2014
BIOLASE Holds Annual Meeting of StockholdersBusiness Wire
Monday, August 25, 2014
BIOLASE Creates Global Commercialization TeamBusiness Wire
Thursday, August 14, 2014
BIOLASE Announces Formation of Dental Professional Advisory BoardBusiness Wire
BIOLASE, INC Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online
Friday, August 8, 2014
BIOLASE, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online
(0)
(0)
